Overview

Olmesartan in Essential Hypertension

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To test the efficacy and safety of olmesartan in patients with essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Sankyo Pharma Gmbh
Treatments:
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil